Burvenich Ingrid
Burvenich Ingrid
Olivia Newton-John Cancer Research Institute
Verified email at onjcri.org.au
Title
Cited by
Cited by
Year
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
P Roswall, M Bocci, M Bartoschek, H Li, G Kristiansen, S Jansson, S Lehn, ...
Nature medicine 24 (4), 463, 2018
832018
Evolution of anti-HER2 therapies for cancer treatment
S Parakh, HK Gan, AC Parslow, IJG Burvenich, AW Burgess, AM Scott
Cancer treatment reviews 59, 1-21, 2017
682017
Biodistribution and planar gamma camera imaging of 123I-and 131I-labeled F (ab′) 2 and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor
IJG Burvenich, S Schoonooghe, P Blanckaert, K Bacher, L Vervoort, ...
Nuclear medicine and biology 34 (3), 257-265, 2007
362007
In vitro and In vivo targeting properties of iodine-123-or iodine-131–labeled monoclonal antibody 14C5 in a non–small cell lung cancer and colon carcinoma model
I Burvenich, S Schoonooghe, B Cornelissen, P Blanckaert, E Coene, ...
Clinical cancer research 11 (20), 7288-7296, 2005
352005
Monoclonal antibody 14C5 targets integrin αvβ5
I Burvenich, S Schoonooghe, L Vervoort, C Dumolyn, E Coene, ...
Molecular cancer therapeutics 7 (12), 3771-3779, 2008
252008
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor
B Cornelissen, V Kersemans, I Burvenich, R Oltenfreiter, ...
Nuclear medicine communications 26 (2), 147-153, 2005
232005
Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008
IJG Burvenich, FT Lee, GA Cartwright, GJ O'Keefe, D Makris, D Cao, ...
Clinical Cancer Research 19 (21), 5984-5993, 2013
182013
Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a
IJG Burvenich, S Parakh, FT Lee, N Guo, Z Liu, HK Gan, A Rigopoulos, ...
Theranostics 8 (15), 4199, 2018
172018
Molecular imaging and quantitation of EphA2 expression in xenograft models with 89Zr-DS-8895a
IJG Burvenich, S Parakh, HK Gan, FT Lee, N Guo, A Rigopoulos, ST Lee, ...
Journal of Nuclear Medicine 57 (6), 974-980, 2016
152016
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer
L Vervoort, I Burvenich, S Staelens, C Dumolyn, E Waegemans, ...
Cancer Biotherapy and Radiopharmaceuticals 25 (2), 193-205, 2010
152010
Effect of cyclosporin A administration on the biodistribution and multipinhole μSPECT imaging of [123 I] R91150 in rodent brain
P Blanckaert, I Burvenich, S Staelens, S De Bruyne, L Moerman, L Wyffels, ...
European journal of nuclear medicine and molecular imaging 36 (3), 446-453, 2009
132009
Radiolabeling, biodistribution, and dosimetry of 123I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo
CMM Lahorte, K Bacher, I Burvenich, ED Coene, C Cuvelier, C De Potter, ...
Journal of Nuclear Medicine 45 (6), 1065-1073, 2004
132004
Receptor occupancy imaging studies in oncology drug development
IJG Burvenich, S Parakh, AC Parslow, ST Lee, HK Gan, AM Scott
The AAPS journal 20 (2), 1-16, 2018
122018
PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1
S Schoonooghe, I Burvenich, L Vervoort, F De Vos, N Mertens, J Grooten
Protein Engineering, Design & Selection 23 (9), 721-728, 2010
122010
Bifunctional aptamer–doxorubicin conjugate crosses the blood–brain barrier and selectively delivers its payload to EpCAM-positive tumor cells
J Macdonald, D Denoyer, J Henri, A Jamieson, IJG Burvenich, N Pouliot, ...
Nucleic acid therapeutics 30 (2), 117-128, 2020
112020
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice
TM Shekhar, IJG Burvenich, MA Harris, A Rigopoulos, D Zanker, ...
BMC cancer 19 (1), 1-18, 2019
112019
Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers
IJG Burvenich, FT Lee, GJ O’Keefe, D Makris, D Cao, S Gong, ...
EJNMMI research 6 (1), 1-13, 2016
112016
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
ZD Nassar, CY Mah, J Dehairs, IJG Burvenich, S Irani, MM Centenera, ...
Elife 9, e54166, 2020
92020
In vitro and in vivo evaluation of 89zr-DS-8273a as a theranostic for anti-death receptor 5 therapy
IJG Burvenich, FT Lee, N Guo, HK Gan, A Rigopoulos, AC Parslow, ...
Theranostics 6 (12), 2225, 2016
92016
New strategies in polypeptide and antibody synthesis: an overview
N Mertens, F Devos, J Leoen, E Van Deynse, A Willems, S Schoonooghe, ...
Cancer Biotherapy and Radiopharmaceuticals 19 (1), 99-109, 2004
92004
The system can't perform the operation now. Try again later.
Articles 1–20